StonvexLoading…
StonvexStonvexStonvexCore line items from TPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.47B | $4.49B | $3.72B | $4.35B |
Operating Income | $301.81M | $576.87M | $428.01M | $746.52M |
Net Income | $241.09M | $458.03M | $343.70M | $576.06M |
EPS (Diluted) | $2.72 | $4.83 | $3.45 | $5.54 |
Total Assets | $4.98B | $4.89B | $4.91B | $4.72B |
Total Liabilities | $1.66B | $1.56B | $1.90B | $1.88B |
Cash & Equivalents | $982.81M | $970.04M | $868.95M | $889.66M |
Free Cash Flow OCF − CapEx | $128.54M | $672.76M | $169.88M | $400.65M |
Shares Outstanding | 84.48M | 92.45M | 95.53M | 101.02M |